Banner Portal
Biocapital, biopolitics, and biosocialities in a global gender context
PDF (Português (Brasil))

Keywords

Gender relations
Sustainable development
Biotechnology for healthcare
Genetics
Body

How to Cite

ACERO, Liliana. Biocapital, biopolitics, and biosocialities in a global gender context: theory and evidence. Cadernos Pagu, Campinas, SP, n. 62, p. e216215, 2021. Disponível em: https://periodicos.sbu.unicamp.br/ojs/index.php/cadpagu/article/view/8667135. Acesso em: 17 jul. 2024.

Abstract

This article discusses dominant trends and countertrends in genetics and biotechnology for healthcare, based mainly on the theoretical approaches of Rose, Haraway, and Braidotti and their followers, which are reformulated for the context of development and directed towards a positive recreation of gender relations and sustainable development. The principal conceptual elements of these theories include: the rise of the biopolitical citizen, the development of biosocialities, and the construction of biopolitics focused on genetic responsibility and body ethics.

PDF (Português (Brasil))

References

AGAMBEN, Giorgio. Homo sacer: o poder soberano e a vida nua Belo Horizonte, Editora UFMG, 2010.

BEESON, Diane; LIPPMAN, Abby. Egg-harvesting for Stem-Cell Research –- Medical Risks and Ethical Problems. Alliance for Humane Biotechnology, 2007. Disponível em: http://www.rbmonline.com/4DCGI/Article/Article?38%091%09=%202503%09. Acesso em: 15 jun. 2019.

BHARADWAJ, Aditya. Ethic of consensibility, subalternethicality: the clinical application of embryonicstem cells in India. BioSocieties (8), 2013, pp.25-40.

BIRCH, Kean; TYFIELD, David. Theorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomics or…What? Science, Technology & Human Values, 00(0), 2012. Disponível em: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.969.8878&rep=rep1&type=pdf. Acesso em: 11 jul. 2019.

BORTZ, Gabriela; VASEN, Federico; ROSEMANN, Achim. Construção das terapias com células-tronco na Argentina: regulação, gestão de riscos e políticas de inovação. Sociologias [online], (2), n. 50, 2019, pp.116-155.

BRAIDOTTI, Rossy. Posthuman Affirmative Politics In: S.E. WILMER, Sam; ZUKAUSKAITE, Audronė (Ed.). Resisting Biopolitics: Philosophical, Political, and Performative Strategies New York, Routledge, 2015, pp.30-57.

BRAIDOTTI, Rossy. Posthuman Humanities. European Educational Research Journal (12),n. 1, 2013, pp.1-19.

BROWN, Phil et alii. Embodied health movements: new approaches to social movements in health. Sociology of Health &Illness, (26), n. 1, 2004, pp.50-80.

DARLING, Marcia. Gender, New Technologies and Development. In: HARCOURT, Wendy; DARLING, Marcia; WOLBRING, Catherine (Ed.). New Technologies and Development. Development, Journal of the Society for International Development, (49), n. 4, 2006, pp.23-27.

DARNOVSKY, Marcy. FDA halts 23 and Me personal genetic tests. Medical Laboratory Observer Março 19, 2014 Disponível em: https://www.mlo-online.com/home/article/13006245/fda-halts-23andme-personal-genetic-tests. Acesso em: 17 Maio 2019.

DICKENSON, Donna. Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good New York, Columbia University Press, 2016.

DICKENSON, Donna. Body Shopping: Converting Body Parts to Profit Oxford, One World Publications, 2008.

DICKENSON, Donna; DARNOVSKY, Marcy. Did a permissive scientific culture encourage the “CRISPR babies” experiment? Nature Biotechnology (37), 2019, pp.355-357.

EINSIEDEL, E.; ADAMSON, H. Stem cell tourism and future stem cellt ourists: policy and ethical implications. Developing World Bioethics, v. 12, n. 1, 2012, pp.35-44.

EUROPEAN Group on Ethics in Science and New Technologies (EGE). Opinion n. 29. The ethical implications of new health technologies and citizen participation. Brussels, European Commission, 2015. Disponível em: https://publications.europa.eu/en/publication-detail/-/publication/e86c21fa-ef2f-11e5-8529-01aa75ed71a1/language-en/format-PDF/source-77404221. Acesso em: 12 jan. 2019.

FEDERACIÓN Argentina de Enfermedades Poco Frecuentes (FADEPOF). Informe sobre ensayo clínico con células madres en pacientes con lesiones oculares, Nov. 2, 2014. Disponível em: http://fadepof.org.ar/noticias/53. Acesso em: 7 ago. 2019.

FERREIRA, Verônica; ÁVILA, Maria Betania; PORTELLA, Ana Paula (Org.). Feminismo e novas tecnologias reprodutivas. Recife, SOS Corpo, 2006.

FRANKLIN, Sarah; KAFTANTZI, Louise. Industry in the Middle: Interview with Intercytex Founder and CSO, Dr Paul Kemp. Science as Culture, Special Issue on Stem Cells, Part II (17), n. 4, 2008, pp.449-462.

FRANKLIN, Sarah; LOCK, Margaret. Remaking Life and Death: Toward an Anthropology of the Biosciences. London, Palgrave, 2003.

GIBBON, Sarah. Charity, breast cancer activism and the iconic figure of the BRCA Carrier. In: GIBBON, Sarah; NOVAS, Carlos (Ed.). Genetics, Biossocialities and the Social Sciences: Making Biologies and Identities Oxon, Routledge, 2008, pp.19-37.

GURA, Theodore. Citizen Science: Amateur experts. Nature (496), 2013, pp.259- 262.

HARAWAY, Donna. Modest_Witness@Second_Millenium. FemaleMan© _Meets_ Oncomouse™ London, Routledge, 1997.

HARAWAY, Donna. A Cyborg Manifesto: Science, Technology and Socialist-Feminism in the Late Twentieth Century. In: HARAWAY, Donna (Ed.). Simians, Cyborgs, and Women: The Reinvention of Nature New York, Routledge, 1991a, pp.149-183.

HARAWAY, Donna. Situated Knowledges: The Science Question in Feminism and the Privilege of Partial Perspective. In: HARAWAY, Donna, Simians, Cyborgs, and Women: The Reinvention of Nature, New York, Routledge, 1991b, pp.183-203.

HARCOURT, Wendy. Editorial: Where Did All the Flowers Go?: Contradictions in world economies. In: HARCOURT, Wendy (Ed.). Sustaining local economies. Development (53), n. 3, 2010, pp.301-304.

HARVEY, Michael; MC MEEKIN, Andy. Publicor Private Economies of Knowledge? Turbulence in the Biological Sciences. London, Edward Elgar, 2007.

HWANG, Seyoung; SLEEBOOM-FAULKNER, Margaret. Bioethical governance in South Korea: tensions between bottom-up movements and professionalization, and scientific citizenship. East Asian Science, Technology and Society: An International Journal (8), n 2, 2014, pp.209-228.

INTERNATIONAL Cellular Medicine Society (ICMS). Presidential Task Force on the Use of Unproven Cellular Therapies: Reference Guide, 2015. Disponível em: http://www.celltherapysociety.org/?page=PTF2015. Acesso em: 22 jan. 2019.

INTERNATIONAL Society For Stem Cell Research (ISSRC). Patient Handbook on Stem Cell Therapies A Report from the International Society for Stem Cell Research. London, ISSRC, 2008. Disponível em: https://www.closerlookatstemcells.org/patient-resources. Acesso em: 22 dez. 2018.

IRWIN, Alan; ELGAARD, Torben; JONES, Kevin. The good, the bad and the perfect: Criticizing engagement practice. Social Studies of Science (43), n. 1, 2012, pp.118-135.

ISASI, Rosario et.al. Disclosure and management of research findings in stem cell research and banking: policy statement. Regenerative Medicine (7),n.3, 2012, pp.439-448.

KASS, Leon. Science, Religion, and the Human Future. Commentary, 2007, pp.36-48.

KURIYAN, Ajay et al. Vision loss after intravitreal injection of autologous “stem cells” for AMD. New England Journal of Medicine (376), 2017, pp.1047-1053.

LOCK, Margaret. Comprehending the body in the era of the epigenome. Current Anthropology (56), 2015, pp.151-177.

LUCIANO, Dana; CHEN, Mel. Has the Queer Ever Been Human? GLQ: A Journal of Lesbian and Gay Studies (21), n. 2-3, 2015, pp.182-195.

MAC DOWELL DOS SANTOS, Maria Cecilia. Quem pode falar, onde e como: uma conversa “não o inocente” com Donna Haraway. cadernos pagu (5), Campinas, Núcleo de Estudos de Gênero-Pagu/Unicamp, 1995, pp.43-72.

MAC MAHON, Dominique. The global industry for unproven stem cell interventions and stem cell tourism. Tissue Engineering and Regenerative Medicine, (11), n. 1, 2014, pp.1-9.

MARGOTTINI, Laura. Italian Parliament Orders€3 Million Trial of Disputed Therapy. Science (340), 31 May 2013,pp.6136. Disponível em: https://science.sciencemag.org/content/340/6136/1028. Acesso em: 15 jun. 2019.

MAZANDERANI, Fadhila; KELLY, Jenny; DUCEY, Ariel. From embodied risk to embodying hope: Therapeutic experimentation and experiential information sharing in a contested intervention for Multiple Sclerosis. Biosocieties (13), n. 1, 2018, pp.232-254.

MBEMBE, Achille. Necropolitics. Public Culture, 15, 2003, pp.11-40.

MONSORES, Natan; LOPES, Cecilia; BESSA BEZERRA, Edilnete; LUNARA SILVA, Natasha. Netnografia e análise bioética de blogs de turismo terapêutico com células-tronco. Ciência e saúde coletiva 21 (10), 2016. Disponível em: https://www.scielosp.org/article/csc/2016.v21n10/3049-3059/. Acesso em: 24 maio 2019.

MORE, Max. The Extropian Principles: A Transhumanist Declaration, 1999. Disponível em: http://www.extropy.org/extprn3.htm. Acesso em: 11 maio 2019.

NIOSI, Jorge; HANEL, Ptr; REID, Susan. The international diffusion of biotechnology: the arrival of developing countries. Journal of Evolutionary Economics, online, 2012. Disponível em: https://www.researchgate.net/profile/Jorge_Niosi2/publication/234074296_The_International_Diffusion_of_Biotechnologies/links/57a3c06e08ae3f4529250812.pdf. Acesso em: 14 maio 2019.

PARKER, Richard. Grassroots Activism, Civil Society Mobilization, and the Politics of the Global HIV/AIDS Epidemic. The Brown Journal of World Affairs (17), n. 2, 2011, pp.21-37.

PETROPANAGOS, Angel; CATTAPAN, Alana; BAYLIS, Francoise; LEADER, Arthur. Social eggfreezing: risk, benefits and other considerations.Canadian Medical Association Journal (16), v.187, n. 9, 2015, pp.666-669.

PINTO, Deirdre; MARTIN, Dominique; CHENHALL, Richard. Chasing cures: Rewards and risks for rare disease patient organizations involved in research. Biosocieties (13), n. 1, 2018, pp.123-147.

PEREZ REQUEJO, José Luis; AZNAR LUCEA, Jorge. Turismo de células madre. Medicina e Morale (1), 2012, pp.32-56.

PRECIADO, Beatriz. The Pharmaco-pornographic Regime: Sex, Gender, and Subjectivity in the Age of Punk Capitalism. In: STRYKER, Susan; AIZURA, Aren (Ed.).Transgender Studies Reader (2), 2006, pp.271-284.

RABERHARISOA, Vololona et alii. From “politics of numbers” to “politics of singularisation”: Patients’ activism and engagement in research on rare diseases in France and Portugal. Biosocieties (9), n. 2, 2014, pp.194-217.

RABINOW, Paul. Artificiality and enlightenment: From sociobiology to biossociality. In: RABINOW, Paul. Essays on the anthropology of reason Princeton, NJ, Princeton University Press, 1996, pp.91-107.

RABINOW, Paul; ROSE, Nikolas. Biopower today. Biosocieties (1), 2006, pp.195-217.

RABINOW, Paul; ROSE, Nikolas (Ed.). The essential Foucault: Selections from essential works of Foucault, 1954-1984. New York and London, New Press, 2003.

RAPP, Rayna. Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America New York, Routledge, 2000.

RISOY, S.; SIRNES, T. The decision: Relations to oneself, authority and vulnerability in the field of selective abortion. Biosocieties (10), n. 3, 2015, pp.317-340.

ROSE, Nikolas.The human sciences in a biological age. Theory Culture & Society (30), 2013, pp.3-34.

ROSE, Nikolas. The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century Oxford, Princeton University Press, 2007.

ROSE, Nikolas; NOVAS, Carlos. Biological citizenship. In: ONG, Andrew; COLLIER, Susan (Ed.). Global assemblages: Technology, politics and ethics as anthropological problems Malden, MA, Blackwell Publishing, 2005, pp.439-63.

ROSEMANN, Achim; BORTZ, Gabriela; VASEN, Federico. Regulatory developments for non hematopoietic stem cell therapeutics: perspectives from the EU, the USA, Japan, China, India, Argentina, and Brazil. In: CHEN, Xiao-Dong (Org.). A road map to non-hematopoietic stem cell-based therapeutics. From the bench to the clinic Londres, Elsevier, 2018, pp.463-92.

SHARON, T Healthy citizenship beyond autonomy and discipline: Tactical engagements with genetic testing. Biosocieties (10), n. 3, 2015, pp.295-316.

SLEEBOOM-FAULKNER, Margaret. The large grey are a between “bonafide” and “rogue” stem cell interventions ethical acceptability and the need to include local variability. Technological Forecasting and Social Change, (109), 2016, pp.76-86.

SUNDER RAJAN, Kaushik. Genomic Capital: Public Cultures and market Logics of Corporate Biotechnology. Science as Culture, Online, (9), 2008a, pp.87-121.

SUNDER RAJAN, K.aushik. Biocapital as an emergent form of life: speculations on the figure of the experimental subject. In: GIBBON, Sarah; NOVAS, Carlos (Ed.) Genetics, Biossocialities and the Social Sciences: Making Biologies and Identities Oxon, Routledge, 2008b, pp.157-188.

THACKER, Eugene. Data MadeFlesh: BiotechnologyandthediscourseofthePosthuman. Cultural Critique (53), 2003, pp.72-97.

THORSTEINSDÓTTIR, Halla et alii. Introduction: promoting global health through biotechnology. Nature Biotechnology (22), Supplement, 2004, pp.DC3-DC7.

WALDBY, Catherine. Oocyte markets: women’s reproductive work in ESCR. New Genetics and Society (27), n. 1, 2008, pp.19-31.

WALDBY, Catherine. Tissue cultures and the production of biovalue. Health (6), 2002, pp.305-323.

WORLD Health Organization (WHO). Genomics and World Health Geneva, WHO, The Advisory Committee on Health Research, 2002.

YOXEN, E. Life as a productive force: capitalizing upon research in molecular biology. In: LEVIDOW, Lynn; YOUNG, Robert (ed.). Science, Technology, and the Labour Process London, Blackrose Press, 1981, pp.66-122.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2021 Liliana Acero

Downloads

Download data is not yet available.